33 C
Lucknow
Online Latest News Hindi News , Bollywood News

India’s Cumulative COVID-19 Vaccination Coverage exceeds 115.23 Cr

English News

With the administration of 72,94,864 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded115.23 Cr (1,15,23,49,358) as per provisional reports till 7 am today.  This has been achieved through 1,18,39,293 sessions.

The break-up of the cumulative figureas per the provisional report till 7 am today include:

HCWs

1st Dose 1,03,81,645
2nd Dose 93,79,604

FLWs

1st Dose 1,83,75,320
2nd Dose 1,62,71,064

Age Group 18-44 years

1st Dose 43,90,36,993
2nd Dose 18,41,86,341

Age Group 45-59 years

1st Dose 17,98,55,199
2nd Dose 10,90,02,159

Over 60 years

1st Dose 11,26,73,120
2nd Dose 7,31,87,913
Total 1,15,23,49,358

The recovery of 12,789 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,38,97,921.

Consequently, India’s recovery rate stands at 98.28%.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 145 consecutive days now.

11,106 new cases were reported in the last 24 hours.

The Active Caseload presentlystands at 1,26,620.Active cases presently constitute 0.37% of the country’s total Positive Cases, which is lowest since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of

11,38,699tests being conducted. India has so far conducted over 62.93 Cr (62,93,87,540) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 0.92% remains less than 2% for the last 56 days now. The Daily Positivity rate reported to be 0.98%. The daily Positivity rate has remained below2% for last 46 days and below 3% for 81 consecutive days now.

Related posts

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More